MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Results for 8-week 48 mg Cohort in Phase 1b Trial of DA-1726 ...

LMNT reports that GLP-1 medications for obesity and diabetes may lead to electrolyte imbalances, highlighting hydration ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the improvement of other conditions in longer studies.

As the new year begins, many are using glucagon-like peptide-1 receptor agonists (GLP-1RAs) for weight loss. While effective, these medications can cause nutritional deficiencies, making dairy a vital ...

SAN ANTONIO, Nov. 25, 2025 – From metabolic villain to hero? The hormone glucagon that raises blood sugar is now getting a second look to see how it actually contributes to insulin secretion, glucose ...

All right. Good morning, everyone, to Jefferies' London Healthcare Conference 2025. My name is Roger Song, one of the senior analyst covering SMID-cap biotech in the U.S. It is my great pleasure to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Mazdutide conferred weight loss of 18.1% at 32 weeks and ...

Severe hypoglycemia (low blood sugar) can cause people with diabetes to have seizures or lose consciousness, which can make it impossible to treat low blood sugar by eating or drinking something ...

Erectile dysfunction (ED) is a common yet frequently underrecognized microvascular complication of diabetes, affecting up to three out of four individuals. Key contributing factors include advancing ...

For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says. Scientists at Duke ...

Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss. Objective: Obesity affects more than 40 ...